SCHEMBL5151689

SCHEMBL5151689

Cc1cc(C(O)(COc2ccc(Cl)cc2)C(F)(F)F)ccc1NC(=O)OC(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
NPY1R P25929 1/20 0.44
NPY2R P49146 1/20 0.44
MAPT P10636 4/20 0.40
GAA P10253 2/20 0.40
LMNA P02545 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
ALOX12 P18054 2/20 0.39
HPGD P15428 2/20 0.38
MAPK1 P28482 1/20 0.38
RXFP1 Q9HBX9 1/20 0.37
TSHR P16473 2/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
F10 P00742 1/20 0.37
PDK1 Q15118 1/20 0.37
PDK2 Q15119 1/20 0.37
PDK3 Q15120 1/20 0.37
PDK4 Q16654 1/20 0.37
P2RX3 P56373 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6237368 0.83 CYP1A2 (0.41) ALDH1A1NPY1RNPY2RMAPTGAA
SCHEMBL5154485 0.82 SMN1; SMN2 (0.43) ALDH1A1NPY1RNPY2RMAPTLMNA
SCHEMBL6239249 0.80 SMN1; SMN2 (0.41) MAPTLMNASMN1; SMN2MAPK1RXFP1
SCHEMBL6242304 0.79 KMT2A (0.47) ALDH1A1NPY1RNPY2RMAPTGAA
SCHEMBL5155508 0.76 SMN1; SMN2 (0.39) ALDH1A1MAPTLMNASMN1; SMN2ALOX12
SCHEMBL5155513 0.76 SMN1; SMN2 (0.39) ALDH1A1MAPTLMNASMN1; SMN2ALOX12
SCHEMBL5731619 0.76 POLB (0.54) ALDH1A1MAPTGAASMN1; SMN2HPGD
SCHEMBL5151363 0.76 ESR1 (0.40) MAPTLMNASMN1; SMN2NPSR1MEN1
SCHEMBL5151209 0.75 TRPV1 (0.42) LMNASMN1; SMN2MAPK1RXFP1MEN1
SCHEMBL29803307 0.75 RXFP1 (0.55) MAPTGAALMNASMN1; SMN2RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070043011-A1 Substituted benzanilide compound and noxious organism controlling agent MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-02-22 US disclosed
EP-1671941-A1 SUBSTITUTED BENZANILIDE COMPOUND AND PEST CONTROL AGENT Nissan Chemical Industries, Ltd. (JP) 2006-06-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043011-A1 Substituted benzanilide compound and noxious organism controlling agent L3MBTL1, L3MBTL3, L3MBTL4 ALDH1A1 888/4885NPY1R 641/4885NPY2R 1033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.